Abstract
Cytochromes P450 (P450s or CYPs) constitute a superfamily of heme-containing monooxygenases and have been shown to play a major role in both xenobiotic and endogenous metabolism. Thanks to the Human Genome Project, the current list of human CYPs should be exhaustive and so far 57 P450 encoding genes have been identified. To date, fif-teen of them, generally called “orphans” cytochromes P450, which were mainly identified by homology research between the sequences of known P450s and genomic sequences or ESTs (Expressed Sequence Tags) databases, are not fully char-acterized. However, tissue distribution, catalytic properties and physiological functions of these “novel P450s” are being analysed and partial results are already available for some of them, including CYP2 (CYP2A13, CYP2R1, CYP2S1, CYP2U1 and CYP2W1), CYP3 (CYP3A43) and CYP4 (CYP4A22, CYP4F12, CYP4F22, CYP4V2, CYP4X1, CYP4Z1) family members. In this review, we present some of the current data characterizing these P450s and discuss their potential involvement in xenobiotic toxicity and carcinogenesis, as well as their physiological relevance in pathology susceptibility.
Keywords: Cytochromes P450, Human Genome Project, xenobiotics, pharmacogenetics
Current Genomics
Title: What Have We Learned from the Novel Human Cytochromes P450 Hidden in the Databases?
Volume: 7 Issue: 5
Author(s): Christelle Cauffiez
Affiliation:
Keywords: Cytochromes P450, Human Genome Project, xenobiotics, pharmacogenetics
Abstract: Cytochromes P450 (P450s or CYPs) constitute a superfamily of heme-containing monooxygenases and have been shown to play a major role in both xenobiotic and endogenous metabolism. Thanks to the Human Genome Project, the current list of human CYPs should be exhaustive and so far 57 P450 encoding genes have been identified. To date, fif-teen of them, generally called “orphans” cytochromes P450, which were mainly identified by homology research between the sequences of known P450s and genomic sequences or ESTs (Expressed Sequence Tags) databases, are not fully char-acterized. However, tissue distribution, catalytic properties and physiological functions of these “novel P450s” are being analysed and partial results are already available for some of them, including CYP2 (CYP2A13, CYP2R1, CYP2S1, CYP2U1 and CYP2W1), CYP3 (CYP3A43) and CYP4 (CYP4A22, CYP4F12, CYP4F22, CYP4V2, CYP4X1, CYP4Z1) family members. In this review, we present some of the current data characterizing these P450s and discuss their potential involvement in xenobiotic toxicity and carcinogenesis, as well as their physiological relevance in pathology susceptibility.
Export Options
About this article
Cite this article as:
Cauffiez Christelle, What Have We Learned from the Novel Human Cytochromes P450 Hidden in the Databases?, Current Genomics 2006; 7 (5) . https://dx.doi.org/10.2174/138920206778604359
DOI https://dx.doi.org/10.2174/138920206778604359 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Biodiversity as a Source of Bioactive Compounds Against Snakebites
Current Medicinal Chemistry Neuronal Regulators and Vascular Dysfunction in Raynauds Phenomenon and Systemic Sclerosis
Current Vascular Pharmacology Statin Therapy and New-onset Diabetes: Molecular Mechanisms and Clinical Relevance
Current Pharmaceutical Design Complex Atheromatosis of the Aortic Arch in Cerebral Infarction
Current Cardiology Reviews Vitamin D3, D2 and Arterial Wall Properties in Coronary Artery Disease
Current Pharmaceutical Design Complementary Role of Herbal Medicine and Exercise in Cardiovascular Disease Prevention and Management: A Review of Evidence
Current Pharmaceutical Design Medical Systemic Therapies for Hepatocellular Carcinoma: Clinical Perspectives and Safety Profile
Current Drug Safety Alpha Adducin (ADD1) Gene Polymorphism and New Onset of Diabetes Under the Influence of Selective Antihypertensive Therapy in Essential Hypertension
Current Hypertension Reviews Editorial [Hot Topic: Benefits, Problems and Alternatives to COX-2 Inhibition (Guest Editor: Angel Lanas)]
Current Topics in Medicinal Chemistry Does A Subclinical Cardiotoxic Effect of Clozapine Exist? Results from a Follow-up Pilot Study
Cardiovascular & Hematological Agents in Medicinal Chemistry Angiotensin II Type 1 Receptor Antagonist as an Angiogenic Inhibitor in Urogenital Cancer
Reviews on Recent Clinical Trials Crofelemer: In HIV Associated Diarrhea and Secretory Diarrhea - A Patent Perspective
Recent Patents on Anti-Infective Drug Discovery Efficacy and Tolerability of Aliskiren/Amlodipine Single-Pill Combinations in Patients who did not Respond Fully to Amlodipine Monotherapy¥
Current Vascular Pharmacology Relationship Between Cigarette Smoking and Other Coronary Risk Factors in Atherosclerosis: Risk of Cardiovascular Disease and Preventive Measures
Current Pharmaceutical Design New Strategies in Treatment of Mineral and Bone Disorders and Associated Cardiovascular Disease in Patients with Chronic Kidney Disease
Recent Patents on Cardiovascular Drug Discovery Differential Contribution of Clinical Amounts of Acetaldehyde to Skeletal and Cardiac Muscle Dysfunction in Alcoholic Myopathy
Current Pharmaceutical Design Editorial [Hot topic: Anti-Angiogenic Agents (Executive Editor: Maurizio Botta and Anna Di Donna)]
Current Pharmaceutical Design Anti-Angiogenic Targets in the Treatment of Advanced Renal Cell Carcinoma
Current Cancer Drug Targets Conceptual Model of Medication Adherence in Older Adults with High Blood Pressure-An Integrative Review of the Literature
Current Hypertension Reviews The Neonatal Kidney: Implications for Drug Metabolism and Elimination
Current Drug Metabolism